Compounds > 3,4-dihydroxyphenylacetaldehyde
Page last updated: 2024-09-03

3,4-dihydroxyphenylacetaldehyde and Lewy Body Disease

3,4-dihydroxyphenylacetaldehyde has been researched along with Lewy Body Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Goldstein, DS1
Goldstein, DS; Sharabi, Y1

Reviews

2 review(s) available for 3,4-dihydroxyphenylacetaldehyde and Lewy Body Disease

ArticleYear
The "Sick-but-not-Dead" Phenomenon Applied to Catecholamine Deficiency in Neurodegenerative Diseases.
    Seminars in neurology, 2020, Volume: 40, Issue:5

    Topics: 3,4-Dihydroxyphenylacetic Acid; Autonomic Nervous System Diseases; Dopamine; Humans; Lewy Body Disease; Norepinephrine; Parkinson Disease; Sympathetic Nervous System

2020
The heart of PD: Lewy body diseases as neurocardiologic disorders.
    Brain research, 2019, 01-01, Volume: 1702

    Topics: 3,4-Dihydroxyphenylacetic Acid; alpha-Synuclein; Catecholamines; Dopamine; Heart; Humans; Lewy Bodies; Lewy Body Disease; Multiple System Atrophy; Myocardium; Neuroimaging; Neurons; Parkinson Disease; Sympathetic Nervous System

2019